Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Teva Pharmaceutical Industries ADR
(NY:
TEVA
)
16.78
+0.21 (+1.27%)
Official Closing Price
Updated: 5:00 PM EST, Nov 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Teva Pharmaceutical Industries ADR
< Previous
1
2
...
14
15
16
17
18
19
20
21
22
...
24
25
Next >
Putin on the brink
February 28, 2022
For the first time in history, Swiss banks have penalized account owners for political actions and joined a SWIFT boycott.
Via
Talk Markets
Red Ink
February 24, 2022
There is little joy in stocks today as even companies reporting good results are being hit by fear of Ukraine sanctions.tbph
Via
Talk Markets
A Receding tide
February 23, 2022
Sanofi and GlaxoSmithKline have developed a new Covid-19 vaccine which they claim is 100% efficient.
Via
Talk Markets
World Markets News For Thursday
February 17, 2022
Ericsson stock lost another 5.27% today in US markets.
Via
Talk Markets
Why Are Teva Pharmaceutical Shares Trading Higher Today?
February 09, 2022
Teva Pharmaceutical Industries Ltd's (NYSE: TEVA)
Via
Benzinga
The Struggles Continue For Generic Drugs Behemoth Teva Pharmaceutical
February 09, 2022
Teva reported light fourth-quarter sales as its own generic drugs struggled and Copaxone sales tumbled.
Via
Investor's Business Daily
Earnings Scheduled For February 9, 2022
February 09, 2022
Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is projected to report quarterly earnings at $0.63 per share on revenue of $25.05 billion.
Via
Benzinga
Psychedelic Drugs Market Growing as Prevalence of Mental Health Issues are Increasing Globally
February 24, 2022
Palm Beach, FL –– February 24, 2022 – FinancialNewsMedia.com News Commentary – The prevalence of mental health disorders has risen exponentially but the development of novel medications has not kept...
Via
FinancialNewsMedia
Exposures
COVID-19
Global Cannabis Extract Market To Surpass $38B By 2030, Key Players Include Tilray, Canopy Growth, Aurora
February 17, 2022
According to Coherent Market Insights, the global cannabis extract market is estimated to be valu...
Via
Benzinga
Israeli Study Reveals Promising Medical Cannabis Results, Especially For PTSD Treatment
February 16, 2022
A recent clinical trial conducted by Soroka University Medical Center and Israeli medical cannabis company Cannbit-Tikun O...
Via
Benzinga
Price To Earnings Ratio Insights For Teva Pharmaceutical
February 07, 2022
Via
Benzinga
Teva, Texas Enter $225M Opioid Settlement Agreement
February 07, 2022
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) has reached a
Via
Benzinga
World Markets News For Monday
February 14, 2022
European markets were down over fear of Ukrainian battles.
Via
Talk Markets
Nuclear Winter
February 11, 2022
Mexico is raising interest rates to 6%, from 5.5%.
Via
Talk Markets
Inflation inflating
February 10, 2022
The Fed will be raising interest rates soon and this will chop the appeal of investments in more vulnerable yield plays.
Via
Talk Markets
Dampening Exuberance
February 09, 2022
The bond sell-off halted today but the Fed's plans mean this will resume.
Via
Talk Markets
The Daily Biotech Pulse: Bristol-Myers Squibb Announces $5B Accelerated Buyback, Qiagen Reaps COVID Testing Windfall, WORLDSymposium Presentations Kick In
February 09, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Teva Pharmaceutical: Q4 Earnings Insights
February 09, 2022
Teva Pharmaceutical Industries (NYSE:TEVA) reported its Q4 earnings results on Wednesday, February 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Teva Reports Fourth Quarter and Full Year 2021 Financial Results
February 09, 2022
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Markets News for Tuesday
February 08, 2022
Oil stocks are up on huge gains.
Via
Talk Markets
Teva Reaches Agreement With Texas to Settle the State’s Opioid-Related Claims
February 07, 2022
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big...
Via
Benzinga
Weakened Tech Stocks
February 03, 2022
There was a 0.5% rise in UK interest rates, twice what had been anticipated and moreover early, because of inflation risks.
Via
Talk Markets
World Markets News for Wednesday
February 02, 2022
Gold and the Euro are up as the greenback loses traction.
Via
Talk Markets
World Markets News for Tuesday
February 01, 2022
Exxon is splitting into 3 with its new restructuring move: upstream; chemicals; and low-carbon.
Via
Talk Markets
Research Finds COVID Pandemic Worsened Health Equity Gap
February 01, 2022
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Drug Troubles
January 28, 2022
The drug sector has both good news and bad.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2022
January 27, 2022
Upgrades
Via
Benzinga
The Best REITs To Buy Right Now Will Pay 8.5% Yield
January 25, 2022
Stocks had a great 2021, if a tad wild - the S&P 500 finished up nearly 27% for the year. But the performance of real estate investment trusts (REITs) last year flat-out blew stocks out of the water -...
Via
Talk Markets
7 Stocks to Buy That Are Nowhere Near Being Overvalued
January 18, 2022
These stocks to buy are above their lows and appear overvalued. They have more upside as growth drivers emerge lifting their prospects.
Via
InvestorPlace
< Previous
1
2
...
14
15
16
17
18
19
20
21
22
...
24
25
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.